Headlines
- Actavis Could Lower Tax Rate With Warner Chilcott Dealat The Wall Street Journal(Fri, May 17)
- Warner Chilcott buy may be Actavis' best takeover defenseat Reuters(Fri, May 17)
- WARNER CHILCOTT PLC FinancialsEDGAR Online Financials(Fri, May 17)
- DEALTALK: Warner Chilcott buy may be Actavis' best takeover defenseat Reuters(Fri, May 17)
- Innovative Therapeutic Development for Duchenne Muscular Dystrophy Moves Niche Stocks Up 300% to 400%: An Expert Portfolio Manager Discusses Investing in Health CareWall Street Transcript(Thu, May 16)
- Bulls return for dose of Warner ChilcottoptionMONSTER(Thu, May 16)
- Drugmaker Actavis' shares upAP(Thu, May 16)
- Ahead of the Bell: Drugmaker Actavis' shares upAP(Thu, May 16)
- Actavis - A Potential Deal With Warner Chilcott Would Further Spur Interest In Actavis Itselfat Seeking Alpha(Thu, May 16)
- [$$] Drug Firms Stalk Actavisat The Wall Street Journal(Wed, May 15)
- Three Monday Upgrades That You May Want to Ignoreat Motley Fool(Wed, May 15)
- Actavis Gaining More From Purchase Than Sale: Real M&Aat Bloomberg(Wed, May 15)
- Actavis rejected $15 billion offer from Mylan: sourceReuters(Tue, May 14)
- Actavis rejected $15 billion offer from Mylan - sourceat Reuters(Tue, May 14)
- Actavis Said to Have Spurned $15 Billion Offer From Mylanat Bloomberg(Tue, May 14)
Press Releases
- Announcement Under Irish Takeover Rules Relevant Securities in IssueGlobeNewswire(Mon, May 13)
- Warner Chilcott Statement Regarding Market SpeculationGlobeNewswire(Fri, May 10)
- Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plcPR Newswire(Fri, May 10)
Reports
- WCRX - Warner Chilcott Plc - Upgraded to a Buy - Company Analysis and ASR Ranking...Alpha Street Research(May 21)
- WARNER CHILCOTT LTD CL A (WCRX) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)
- Market Edge Equity Research ReportMarket Edge(May 20)
